ASH abstracts

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
rccola335
Posts: 305
Joined: Sat Sep 28, 2019 10:00 pm

ASH abstracts

Post by rccola335 » Wed Sep 30, 2020 5:09 pm

i would assume we will know next week (oct 5th) about what Geron has had accepted for the December ASH meeting - this is from their website:
Notification regarding acceptance or rejection of abstracts will be sent to the presenting author in early-October 2020 by email; consequently, an accurate email address is critical. If your abstract is accepted, the email will specify whether it is accepted as plenary, oral, or poster presentation or whether it has been selected to be published online only. If you have not received an email notification by October 5, 2020, contact ASHabstracts@hematology.org. Rejection notifications will also be sent at that time.

rccola335
Posts: 305
Joined: Sat Sep 28, 2019 10:00 pm

Re: ASH abstracts

Post by rccola335 » Wed Sep 30, 2020 5:19 pm

looks like somewhere else ASH says the abstracts will go online Nov 5th - this is similar to 2019 when Geron released this info in a press release - Geron will know next week what they got accepted and for what type of presentation but the public won't know for a month

biopearl123
Posts: 1665
Joined: Fri Jul 20, 2018 5:13 pm

Re: ASH abstracts

Post by biopearl123 » Wed Sep 30, 2020 6:03 pm

I agree it is unlikely they will PR until early Nov re abstract
Tiles. But in the unlikely event of a plenary acceptance they might tell us in Oct. unlikely. bp

Zhears
Posts: 74
Joined: Mon Oct 08, 2018 12:19 pm

Re: ASH abstracts

Post by Zhears » Wed Sep 30, 2020 11:57 pm

Mentioning the Ash abstracts in the last conference was unusual and is possibly pointing to the fact that they already know.

biopearl123
Posts: 1665
Joined: Fri Jul 20, 2018 5:13 pm

Re: ASH abstracts

Post by biopearl123 » Thu Oct 01, 2020 2:23 am

Zhears, right you are, have never seen that kind of statement before. Usual Acknowledgement of acceptance
Of abstract/poster early Oct. Release of title and abstract usually early November. Not sure what Dr Scarletts statement implies, either he was very sure of likelihood of acceptance or he already knew.

bucbeard
Posts: 80
Joined: Wed Jul 25, 2018 12:30 am

Re: ASH abstracts

Post by bucbeard » Wed Oct 21, 2020 10:32 pm

https://www.healio.com/news/hematology- ... exposition

Dr. Fauci is this year's guest speaker. Will draw some extra eyeballs for sure...hopefully we have some big news to share to the community, the world.

biopearl123
Posts: 1665
Joined: Fri Jul 20, 2018 5:13 pm

Re: ASH abstracts

Post by biopearl123 » Thu Oct 22, 2020 12:02 am

What a great choice! Dr. Fauci is a man of honor, intellect and a clarion voice of informed honesty. It is a shame he has been subjected to such disrespectful treatment by our current leaders. While we are on the subject of COVID, consider that the latest job posting appears yet to be filled. Probably because there is no rush. Dr. Scarlett has a very difficult situation to deal with, namely enrollment. Consider the rising cases in countries in which many of the medical centers devoted to the MDS study are located. In Israel recently, there were 9000 cases in one day reported. Extrapolated to a population of the US that would mean almost 350,000 cases in one day. The Czech Republic, a country we thought had it all under control, leads Europe in a resurgence keeping company with Spain, Italy, need I say more. No medical center can avoid having their focus on elective research studies diverted until COVID is under control. And despite the fantasy mongers it is hardly under control. At least at ASH Dr. Fauci will have the opportunity to address his fellow scientists and not politicians. And now to return to a point we have discussed previously. Given the acute need to help the sick why has provisional approval not been granted to Imetelstat? These are not normal times. Studies will take much longer and patients will not receive the meds they need. Enrollment problems do not belong to Dr. Scarlett, Geron is doing their best. In this case the enrollment problem is really an access problem and should be laid at the feet of the FDA and the EU. (I remain hopeful that the EU will at least allow MA for MF, there is surely enough data there and I submit the following thoughts: Its pretty simple actually, and this may seem a digression but it is not. If you take a baggie and put a few cc of water in it and measure the pressure in the bag it is close to zero. If you take the same few cc and try to add it to an already full baggie the pressure skyrockets. If that baggie is a spleen, well you can figure it out. Small reductions in spleen volume and capsular pressure lead to large improvements in symptoms. The FDA and the EU have been shown that in spades. That alone should be enough. But add that to the rest of the data and what do you have? You have a drug that cries out for approval. Well no, that would be the patients we hear crying. Maybe Dr. Fauci can open some ears and highlight how the patients in the MDS/MF populations are at tremendous risk for COVID morbidity and mortality. Regards to all, stay healthy, bp

Post Reply